Article thumbnail

Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia

By Tsige Ketema, Kefelegn Getahun and Ketema Bacha
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3076248
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1995). A Foundation for Analysis in the Health Sciences. 6 edition.
  2. (1998). Alamerew D: Response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in Areka and Sawla, Southern Ethiopia. Ethiop J Health Dev
  3. (2010). AM: Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Acta Trop
  4. (2008). Annerberg A, de Radigues X, Nosten F: Plasmodium vivax resistance to chloroquine in Dawei, Southern Myanmar. Trop Med Int Health
  5. (2001). Anti-Malarial Drug Resistance. Report of a WHO Consultation.
  6. (1997). Assessment of the pharmacodynamic properties of antimalarial drug in vivo. Antimicrob Agents Chemother
  7. (2009). Bacha Ketema, Berhanu Tarekegn, Petros Beyene: Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia. Malaria J
  8. (2004). British pharmacopeia;
  9. (1946). Chloroquine for the treatment of acute attacks of vivax malaria.
  10. (2004). Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother
  11. (1986). Chloroquine resistant Plasmodium falciparium malaria in Ethipia. Lancet
  12. (1989). DC: Plasmodium vivax resistance to choloroquine? Lancet
  13. (1996). DJ: Failure of chloroquine treatment for malaria in the highlands of Ethiopia. Trans R Soc Trop Med Hyg
  14. (2003). Emergency Situation in Kambaata - Tambaaro Zone and Halaba Special Woreda.
  15. (1991). Gebrat Y: Response of Plasmodium falciparum to chloroquine in hospitalized patients at sidamo regional hospital.
  16. Hoffman SL: Primaquine therapy of malaria. Clin Infec Dis .
  17. (1993). Hoffman SL: Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet
  18. (2003). KC: Chloroquine resistant P. vivax malaria in Peru. Am J Trop Med Hyg
  19. Ministry of Health of Ethiopia): Assessment of the therapeutic efficacy of antimalarial drugs in Ethiopia, Addis Ababa,
  20. (2007). Ministry of Health of Ethiopia): Entomological profile of malaria in Ethiopia.
  21. (2004). Ministry of Health of Ethiopia): Malaria Diagnosis and Treatment Guidelines for Health Workers,
  22. (2009). Office: Annual Health Report, South Nations and Nationalities Peoples Region (SNNPR), Halaba district;
  23. (2001). Plowe CV: Chloroquine-resistant malaria.
  24. (2004). Quality of anti-malarial drugs used for self-medication. Am J Trop Med Hyg
  25. (2009). Resistance to Therapies for Infection by Plasmodium vivax. Clin Microbiol
  26. (1999). Susceptibility of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine in Humera and Alamata areas in northern Ethiopia. Report to the Ethiopian Science and Technology Commission Addis Ababa, Ethioopia;
  27. (1999). Tedla T: An in vivo study of falciparium malaria sensitivity to chloroquine in unstable malaria endemic area of central Ethiopia. Ethiopian Med J
  28. (2008). Tesfaye Gezagegn, Elhassan Ibrahim, Muchohi Simon, kokwaro Gilbert, Assefa Abraham: Chloroquine resistant Plasmodium vivax malaria in Debre zeit,
  29. (1998). The Pharmaceutical Press, Her Majesty’s Stationery Office.
  30. (2003). Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P.vivax malaria in Indonesian Papua. Am J Trop Med Hyg
  31. (2003). VP: Clearance of drug-resistant parasites as a model for protective immunity in P. falciparum malaria. Am J TropMed Hyg